Cases that scored 2+ (moderate staining in >10% of tumor cells) are subjected to an additional (fluorescence/chromogen) in situ hybridization (FISH or CISH) assay to determine the HER2 gene amplification levels at the chromosomal level [15,16,17,18]. The gene discussed is ERBB2; the disease is neoplasm.